RIGEL PHARMACEUTICALS INC 4
4 · RIGEL PHARMACEUTICALS INC · Filed Jan 13, 2017
Insider Transaction Report
Form 4
Duliege Anne-Marie
Chief Medical Officer
Transactions
- Sale
Common Stock
2017-01-03$2.41/sh−5,000$12,028→ 0 total
Holdings
- 5,000
Common Stock
Footnotes (3)
- [F1]The Reporting Person purchased these shares on 12/31/16 under the Employee Stock Purchase Plan.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2016
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.36 to $2.44, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote three (3) of this Form 4.